CBIO Earnings

Quarterly EPS
$0.04
Q1 2023
$0.03
Q2 2023
$0.06
Q3 2023
$-4.93
Q2 2025
$-1.27
Q3 2025
$-3.96
Q4 2025
$-0.70
Q1 2026
$-0.74
Q2 2026
Latest RevenueN/A
Latest Net Income-24837000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.740-24837000+85.0%
Q1 2026-$0.701.0M-23283000-96.8%-1,266.7%
Q4 2025-$3.9610.8M-92397000-63.0%-13,300.0%
Q3 2025-$1.270-24607000-100.0%-3,275.0%
Q2 2025-$4.930-21790000-100.0%-2,494.7%
Q3 2023$0.0632.0M7.5M+102.5%
Q2 2023$0.0329.3M3.8M-99.9%
Q1 2023$0.0424.9M4.2M+3,039.9%+100.6%
Q4 2022-$0.19101.5M-27898000
Q3 2022-$2.400-4884000
Q2 2022$24.60051.6M
Q1 2022-$6.90794.0K-14536000
Crescent Biopharma (CBIO) — Earnings